Sin conexión a internet: se muestra la versión guardada de la página.

Amgen Inc

USUSD
← Al Screener

Amgen Inc (MX:AMGN) — Biotechnology: Biological Products (No Diagnostic Substances). Número de bolsas en las que cotizan las acciones de la empresa: 4. En esta página: cotización y gráfico, dividendos, principales accionistas e historial del número de acciones.

Sobre la Empresa

Sitio Web
amgen.com
Relaciones con los Inversores
investors.amgen.com/
Sector
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Sede Central
Thousand Oaks, United States
Consejero Delegado
Robert A. Bradway
Empleados
17 900
Fundada
1980
Cotiza Desde
29.02.2008 (MX:AMGN)
Acciones en Circulación
540.63 M a 2026-07-30
Capital Flotante
539.16 M
Capitalización Bursátil
226.05 mil M USD
Insiders
0.23%
Inversores Institucionales
85.02%
Industria (SIC)
Biological Products, (No Diagnostic Substances)
Forma Jurídica
XTIQ
ISIN
US0311621009
LEI
62QBXGPJ34PQ72Z12S66
P/E
25.9
Ratio de Reparto
60.4%
FCF
10.2 mil M USD
Pagos / FCF
52%
Deuda
57.3 mil M USD
4.3 a. de FCF
Racha de Dividendos
15 a.
Beneficios, FCF y dividendos pagados — para los 12 meses hasta 30.06.2026 (el último informe de la compañía).
Descripción

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including PROLIA, REPATHA, OTEZLA, ENBREL, EVENITY, XGEVA, TEPEZZA, BLINCYTO, NPLATE, TEZSPIRE, KYPROLIS, ARANESP, KRYSTEXXA AND VECTIBIX, MVASI, PAVBLU, UPLIZNA, IMDELLTRA/IMDYLLTRA, AMJEVITA/AMGEVITA, TAVNEOS, NEULASTA, LUMAKRAS/LUMYKRAS, RAVICTI, PARSABIV, AIMOVIG, WEZLANA/WEZENLA, AND PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; BEONE MEDICINES LTD. to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. The company was incorporated in 1980 and is headquartered in Thousand Oaks, California.

anuncio

Bolsas y Tickers

BolsaTickerMonedaPrecioTipo
US USA StocksAMGN principalUSD417.57 +0.65%acciones ordinarias
HK Hong Kong Stock Exchange4332 secundariaHKD—
LSE London Stock Exchange0R0T IOBUSD411.854 +1.17%acciones ordinarias
MX Mexican Stock ExchangeAMGN secundariaMXN7 500.0098 +0.00%acciones ordinarias
XETRA XetraAMG secundariaEUR367.95 -1.39%acciones ordinarias

Precio en 3 Meses

día alcista día bajista fecha ex-dividendo fecha de pagoPasa el cursor / toca un día — precios de apertura, cierre, máximo y mínimo

Dividendos

Por año, MX:AMGN: 180.7291 MXN (4 pagos)

Amgen Inc (AMGN) paga dividendos trimestralmente. Por año (12 meses hasta e incluyendo el último pago anunciado): 180.7291 MXN por acción (pagos: 4). Eso representa aproximadamente el 2.41% del precio actual de la acción. Según el historial de pagos, se espera la próxima fecha ex-dividendo alrededor de 20.11.2026. Historial de dividendos ininterrumpido: 15 años.

Fecha ExPagoImporte%TipoTicker
2026-08-21—45.8186 MXN0.6/2.4 %trimestralMX:AMGN
2026-05-15—45.8186 MXN0.8/3.1 %trimestralMX:AMGN
2026-02-13—45.8186 MXN0.7/2.8 %trimestralMX:AMGN
2025-11-21—43.2732 MXN0.7/2.8 %trimestralMX:AMGN
2025-08-22—43.2732 MXN0.8/3.1 %trimestralMX:AMGN
2025-05-16—43.2732 MXN0.8/3.1 %trimestralMX:AMGN
2025-02-14—43.2732 MXN0.7/2.7 %trimestralMX:AMGN
2024-11-19—40.9095 MXN0.6/2.5 %trimestralMX:AMGN
2024-08-16—40.9095 MXN0.7/2.7 %trimestralMX:AMGN
2024-05-16—40.9095 MXN0.8/3.2 %trimestralMX:AMGN
2024-02-15—40.9095 MXN0.8/2.9 %trimestralMX:AMGN
2023-11-16—38.7277 MXN0.8/3.3 %trimestralMX:AMGN
2023-08-17—38.7277 MXN0.8/3.3 %trimestralMX:AMGN
2023-05-17—38.7277 MXN0.9/3.6 %trimestralMX:AMGN
2023-02-14—38.7277 MXN0.8/3.1 %trimestralMX:AMGN
2022-11-16—35.2731 MXN0.7/2.6 %trimestralMX:AMGN
2022-08-17—35.2731 MXN0.7/2.8 %trimestralMX:AMGN
2022-05-16—35.2731 MXN0.7/2.1 %trimestralMX:AMGN
2022-02-14—35.2731 MXN0.7/1.4 %trimestralMX:AMGN
2021-11-16—32.0003 MXN0.7/0.7 %trimestralMX:AMGN

Principales Accionistas

TitularParticipaciónAccionesFecha del Informe
Blackrock Inc.9.13%49.36 M2026-06-30
Vanguard Capital Managem…6.52%35.25 M2026-06-30
State Street Corporation5.65%30.56 M2026-06-30
Capital World Investors5.38%29.08 M2026-06-30
VANGUARD INDEX FUNDS-Van…3.17%17.13 M2026-06-30
Invesco Ltd.3.02%16.32 M2026-06-30
Geode Capital Management…2.9%15.7 M2026-06-30
Charles Schwab Investmen…2.78%15.03 M2026-06-30
Vanguard Portfolio Manag…2.75%14.85 M2026-06-30
VANGUARD INDEX FUNDS-Van…2.59%13.99 M2026-06-30
Morgan Stanley2.53%13.65 M2026-06-30
Invesco QQQ Trust, Serie…2.15%11.61 M2026-08-31
SCHWAB STRATEGIC TRUST-S…1.81%9.79 M2026-05-31
Income Fund of America1.44%7.76 M2026-06-30
iShares Trust-iShares Co…1.35%7.28 M2026-07-31
Wells Fargo & Company1.34%7.24 M2026-06-30
AMERICAN BALANCED FUND1.31%7.09 M2026-06-30
Fidelity Concord Street…1.29%6.98 M2026-07-31
SPDR S&P 500 ETF TRUST-S…1.22%6.6 M2026-08-31
WASHINGTON MUTUAL INVEST…1.16%6.27 M2026-06-30
BRADWAY ROBERT A (Chief…≈0.12%657 2992026-05-05
SANTOS ESTEBAN (Officer)≈0.02%84 2792026-05-05
GORDON MURDO (Officer)≈0.01%51 8372026-05-05
GRIFFITH PETER H. (Chief…≈0.01%50 7062026-05-05
REESE DAVID M. (Chief Te…≈0.01%42 8122026-05-05
GRAHAM JONATHAN P (Gener…≈0.01%40 2112026-05-05
BRADNER JAMES E. (Office…≈0.01%30 4622026-05-05
ECKERT ROBERT ANDREW (Di…≈0%26 2512026-05-19
JACKS TYLER (Director)≈0%18 2842026-05-19
KULLMAN ELLEN JAMISON (D…≈0%14 5362026-05-19